cisapride has been researched along with Dysphagia in 9 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This hypothesis was tested in a small pilot study treating functional dysphagia with cisapride." | 3.68 | Oesophageal reflex responses: abnormalities of the enteric nervous system in patients with oesophageal symptoms. ( Bancewicz, J; Marples, M; O'Hanrahan, T; Thompson, D; Williams, D, 1992) |
| "Only surgery improved regurgitation." | 1.30 | The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture. ( Gadenstaetter, M; Glaser, K; Hinder, RA; Profanter, C; Wetscher, GJ, 1999) |
| "Eighty GERD patients with either dysphagia or respiratory symptoms were studied by means of a detailed symptom questionnaire, upper gastrointestinal endoscopy, esophageal manometry, 24-h esophageal pH monitoring and a barium esophagogram." | 1.30 | Respiratory symptoms and dysphagia in patients with gastroesophageal reflux disease: a comparison of medical and surgical therapy. ( Gadenstätter, M; Profanter, C; Schwab, GP; Wetscher, GJ; Wykypiel, H, 1999) |
| "Esophageal leiomyomatosis is triggered by diffuse proliferation of smooth muscle cells in the wall of the entire esophagus." | 1.29 | [Leiomyomatosis of the esophagus]. ( Grönniger, J; Hillemanns, A; Oglodek, C; Reinbold, WD, 1994) |
| "No episode of probable/possible aspiration pneumonia was observed during the follow-up." | 1.29 | Prevention of aspiration pneumonia during long-term feeding by percutaneous endoscopic gastrostomy: might cisapride play any role? An open pilot study. ( Donati, D; Gilli, G; Malacarne, P; Nielsen, I; Sartori, S; Tassinari, D; Trevisani, L, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reinbold, WD | 1 |
| Oglodek, C | 1 |
| Hillemanns, A | 1 |
| Grönniger, J | 1 |
| Sartori, S | 1 |
| Trevisani, L | 1 |
| Tassinari, D | 1 |
| Nielsen, I | 1 |
| Gilli, G | 1 |
| Donati, D | 1 |
| Malacarne, P | 1 |
| Sharman, JM | 1 |
| McDougall, NI | 1 |
| Johnston, BT | 1 |
| Kee, F | 1 |
| Collins, JS | 1 |
| McFarland, RJ | 1 |
| Love, AH | 1 |
| Inder, TE | 1 |
| Volpe, JJ | 1 |
| Wetscher, GJ | 2 |
| Glaser, K | 1 |
| Gadenstaetter, M | 1 |
| Profanter, C | 2 |
| Hinder, RA | 1 |
| Gadenstätter, M | 1 |
| Wykypiel, H | 1 |
| Schwab, GP | 1 |
| Chattopadhyay, A | 1 |
| Singh, S | 1 |
| Sood, A | 1 |
| Wanchu, A | 1 |
| Bambery, P | 1 |
| O'Hanrahan, T | 1 |
| Bancewicz, J | 1 |
| Thompson, D | 1 |
| Marples, M | 1 |
| Williams, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study[NCT02081404] | 98 participants (Actual) | Interventional | 2009-03-01 | Completed | |||
| Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study[NCT01574573] | 52 participants (Actual) | Interventional | 2009-06-30 | Terminated (stopped due to Closed due to lack of recruitment) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cisapride and Dysphagia
| Article | Year |
|---|---|
Recovery of congenital isolated pharyngeal dysfunction: implications for early management.
Topics: Cisapride; Deglutition Disorders; Electromyography; Female; Humans; Infant, Newborn; Neurologic Exam | 1998 |
8 other studies available for cisapride and Dysphagia
| Article | Year |
|---|---|
[Leiomyomatosis of the esophagus].
Topics: Anti-Ulcer Agents; Biopsy; Cisapride; Combined Modality Therapy; Deglutition Disorders; Esophageal N | 1994 |
Prevention of aspiration pneumonia during long-term feeding by percutaneous endoscopic gastrostomy: might cisapride play any role? An open pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cisapride; Deglutition Disorders; Enteral Nutrition; Fem | 1994 |
Cisapride to relieve dysphagia.
Topics: Aged; Aged, 80 and over; Cisapride; Deglutition Disorders; Humans; Male; Piperidines; Serotonin Anta | 1993 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cisapride; | 1999 |
Respiratory symptoms and dysphagia in patients with gastroesophageal reflux disease: a comparison of medical and surgical therapy.
Topics: Cisapride; Deglutition Disorders; Female; Fundoplication; Gastroesophageal Reflux; Gastrointestinal | 1999 |
Cervical osteophyte induced dysphagia.
Topics: Anti-Ulcer Agents; Cervical Vertebrae; Cisapride; Deglutition Disorders; Esophageal Stenosis; Gastro | 2001 |
Oesophageal reflex responses: abnormalities of the enteric nervous system in patients with oesophageal symptoms.
Topics: Adult; Aged; Catheterization; Cisapride; Deglutition Disorders; Esophageal Diseases; Esophagus; Fema | 1992 |